Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4499)
All Articles published online
|
Publishing Process of This Article
|
Apr 27, 2022 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gantzel RH, Kjær MB, Jepsen P, Aagaard NK, Watson H, Gluud LL, Grønbæk H. Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis. World J Hepatol 2022; 14(4): 827-845 [PMID: 35646272 DOI: 10.4254/wjh.v14.i4.827] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i4/827.htm |
| Number | Citing Articles |
| 1 |
Rasmus H. Gantzel, Emilie E. Møller, Niels K. Aagaard, Hugh Watson, Peter Jepsen, Henning Grønbæk. Randomized clinical trial on safety of the natriuretic peptide ularitide as treatment of refractory cirrhotic ascites. Hepatology Communications 2024; 8(7) doi: 10.1097/HC9.0000000000000481
|